Then, the Ozempic boom happened. Madison didn’t know what to expect from Ozempic other than that it was helping people lose weight. So, in March 2023, Madison started GLP-1 medication through Claya, a ...
Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
Lupin has received tentative approval from the Food and Drug Administration for darunavir, cobicistat, emtricitabine, and ...
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several people who developed eye conditions soon after they began taking semaglutide ...